Search For Articles | Metabolism and Target Organ Damage

Commentary

Open Access

25 Aug 2026

Finerenone in type 1 diabetes and chronic kidney disease

Bertram Pitt, ...Christopher S. Wilcox

Views: Cited: Crossref

Original Article

Open Access

5 Aug 2026

Associations of cardiovascular-kidney-metabolic syndrome stage with trabecular bone score and bone mineral density

Jiashuang Lin, ...Ling Chen

Views: Cited: Crossref

Original Article

Open Access

24 Jul 2026

Predicting cardiovascular-kidney-metabolic multimorbidity in Chinese adults with overweight and obesity using machine learning: an internal evaluation

Xin Li, ...Shiwei Liu

Views: Cited: Crossref

Original Article

Open Access

24 Jun 2026

History of gestational diabetes mellitus or hypertensive disorders of pregnancy and risk of chronic kidney disease

Yongliu Wang, ...Xiong-Fei Pan

Views: Cited: Crossref

Review

Open Access

10 Jun 2026

Podocyte lipotoxicity in diabetic kidney disease: mechanisms and targets

Mengsi Hu, ...Chaoyue Yan

Views: Cited: Crossref

Original Article

Open Access

17 Mar 2026

Immunometabolic drivers of renal fibrosis and potential therapeutic targets in diabetic kidney disease

Dongsen Hu, ...Linhua Zhao

Views: Cited: Crossref

Review

Open Access

27 Jan 2026

Novel insights into the purinergic P2X7 receptor signaling in obesity and cardiovascular-kidney-metabolic syndrome: a brief overview

Angelo Di Vincenzo

, ...Marco Rossato

Views: Cited: Crossref

Original Article

Open Access

24 Dec 2025

Associations of estimated pulse wave velocity with cardiovascular-kidney-metabolic syndrome in U.S. adults: the role of sex and ethnicity (NHANES 1999-2018)

Shaowei Yi, ...Qin Yu

Views: Cited: Crossref

Original Article

Open Access

4 Sep 2025

The global burden of diabetes-related chronic kidney disease from 1990 to 2021, with projections to 2036

Wen-Yue Liu, ...Dan-Qin Sun

Views: Cited: Crossref

Review

Open Access

4 Aug 2025

Type 1 diabetes mellitus: the liver’s role, sex-specific outcomes, and advances in disease-modifying therapies - a literature review

Jean Paule Joumaa, ...Hilda E. Ghadieh

Views: Cited: Crossref

Review

Open Access

24 Oct 2024

Obesity, kidney and metabolic bariatric surgery: a surgeon's narrative review

Yoona Chung

, ... Yong Jin Kim

Views: Cited: Crossref

Review

Open Access

6 Apr 2024

Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review

Amedeo Lonardo

Views: Cited: Crossref

Original Article

Open Access

31 Mar 2024

Major adverse foot events and functional mobility deficits associated with diabetic neuropathy and nephropathy

David R. Sinacore

, ... Paul W. Kline

Views: Cited: Crossref

Commentary

Open Access

18 Oct 2023

PNPLA3 rs738409 polymorphism and kidney dysfunction: an association beyond nonalcoholic fatty liver disease?

Alessandro Mantovani

, Giovanni Targher

Views: Cited: Crossref

Review

Open Access

29 Sep 2022

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Amedeo Lonardo

, Gjin Ndrepepa

Views: Cited: Crossref

Editorial

Open Access

10 Jul 2022

From liver fat to full-blown metabolic disorder: the kidney as target organ

Maria L. Petroni, Giulio Marchesini

Views: Cited: Crossref

Review

Open Access

18 Nov 2021

The Fatty liver Index (FLI) 15 years later: a reappraisal

Amedeo Lonardo

, ... Claudio Tiribelli

Views: Cited: Crossref

Review

Open Access

16 Aug 2021

Risk of cardio-nephro-metabolic disease from NAFLD to MAFLD: fact or fiction?

Ramzi Hassouneh, ... Chandra Bhati

Views: Cited: Crossref

Search For

Finerenone in type 1 diabetes and chronic kidney disease

Associations of cardiovascular-kidney-metabolic syndrome stage with trabecular bone score and bone mineral density

Predicting cardiovascular-kidney-metabolic multimorbidity in Chinese adults with overweight and obesity using machine learning: an internal evaluation

History of gestational diabetes mellitus or hypertensive disorders of pregnancy and risk of chronic kidney disease

Podocyte lipotoxicity in diabetic kidney disease: mechanisms and targets

Immunometabolic drivers of renal fibrosis and potential therapeutic targets in diabetic kidney disease

Novel insights into the purinergic P2X7 receptor signaling in obesity and cardiovascular-kidney-metabolic syndrome: a brief overview

Associations of estimated pulse wave velocity with cardiovascular-kidney-metabolic syndrome in U.S. adults: the role of sex and ethnicity (NHANES 1999-2018)

The global burden of diabetes-related chronic kidney disease from 1990 to 2021, with projections to 2036

Type 1 diabetes mellitus: the liver’s role, sex-specific outcomes, and advances in disease-modifying therapies - a literature review

Obesity, kidney and metabolic bariatric surgery: a surgeon's narrative review

Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review

Major adverse foot events and functional mobility deficits associated with diabetic neuropathy and nephropathy

PNPLA3 rs738409 polymorphism and kidney dysfunction: an association beyond nonalcoholic fatty liver disease?

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

From liver fat to full-blown metabolic disorder: the kidney as target organ

The Fatty liver Index (FLI) 15 years later: a reappraisal

Risk of cardio-nephro-metabolic disease from NAFLD to MAFLD: fact or fiction?

Committee on Publication Ethics

Portico

Committee on Publication Ethics

Portico